ERIC J LOUMEAU, the CHIEF LEGAL OFFICER of $ANAB, sold 1,841 shares of the company on 01-07-2026 for an estimated $84,925. We received data on the trade from a recent SEC filing. This was a sale of approximately 16.0% of their shares of this class of stock. Following this trade, they now own 9,657 shares of this class of $ANAB stock.
$ANAB Insider Trading Activity
$ANAB insiders have traded $ANAB stock on the open market 24 times in the past 6 months. Of those trades, 0 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $ANAB stock by insiders over the last 6 months:
- ERIC J LOUMEAU (CHIEF LEGAL OFFICER) has made 0 purchases and 11 sales selling 53,503 shares for an estimated $2,344,629.
- DENNIS MULROY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 5 sales selling 30,996 shares for an estimated $1,436,886.
- DANIEL FAGA (President, CEO) has made 0 purchases and 2 sales selling 24,511 shares for an estimated $1,077,369.
- PAUL F. LIZZUL (Chief Medical Officer) has made 0 purchases and 3 sales selling 7,954 shares for an estimated $358,334.
- HOLLINGS RENTON has made 0 purchases and 2 sales selling 10,231 shares for an estimated $200,713.
- J. ANTHONY WARE sold 3,900 shares for an estimated $193,342
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ANAB Hedge Fund Activity
We have seen 80 institutional investors add shares of $ANAB stock to their portfolio, and 71 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST LIGHT ASSET MANAGEMENT, LLC removed 2,549,432 shares (-72.0%) from their portfolio in Q3 2025, for an estimated $78,063,607
- MILLENNIUM MANAGEMENT LLC added 1,315,688 shares (+646.4%) to their portfolio in Q3 2025, for an estimated $40,286,366
- UBS GROUP AG removed 1,197,237 shares (-94.1%) from their portfolio in Q3 2025, for an estimated $36,659,396
- CITIGROUP INC removed 975,954 shares (-93.3%) from their portfolio in Q3 2025, for an estimated $29,883,711
- BANK OF AMERICA CORP /DE/ removed 949,558 shares (-88.2%) from their portfolio in Q3 2025, for an estimated $29,075,465
- ASSENAGON ASSET MANAGEMENT S.A. added 822,975 shares (+4852.7%) to their portfolio in Q3 2025, for an estimated $25,199,494
- SOFINNOVA INVESTMENTS, INC. removed 778,094 shares (-75.4%) from their portfolio in Q3 2025, for an estimated $23,825,238
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ANAB Analyst Ratings
Wall Street analysts have issued reports on $ANAB in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 01/07/2026
- Stifel issued a "Buy" rating on 12/11/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/24/2025
- Wedbush issued a "Outperform" rating on 11/24/2025
- Barclays issued a "Overweight" rating on 10/13/2025
- JP Morgan issued a "Overweight" rating on 07/24/2025
To track analyst ratings and price targets for $ANAB, check out Quiver Quantitative's $ANAB forecast page.
$ANAB Price Targets
Multiple analysts have issued price targets for $ANAB recently. We have seen 11 analysts offer price targets for $ANAB in the last 6 months, with a median target of $56.0.
Here are some recent targets:
- Michael Yee from UBS set a target price of $70.0 on 01/07/2026
- Etzer Darout from Barclays set a target price of $55.0 on 12/17/2025
- Alex Thompson from Stifel set a target price of $56.0 on 12/11/2025
- Martin Fan from Wedbush set a target price of $50.0 on 11/24/2025
- Emily Bodnar from HC Wainwright & Co. set a target price of $51.0 on 11/24/2025
- John Lee from Truist Securities set a target price of $36.0 on 11/10/2025
- Yatin Suneja from Guggenheim set a target price of $100.0 on 11/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
